id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1982-N-0005-0007,FDA,FDA-1982-N-0005,Notice of Final Rule re Lebeling for Oral and Rectal Over-the-Counter Drug Products Containing Aspirin and Nonaspirin Salicylates; Reye's Syndrome Warning,Notice,Notice of Final Rule,2003-04-22T04:00:00Z,2003,4,,,2016-10-13T18:03:59Z,,0,0,090000648050d796